Background Older and more mature football players have been reported to gain advantages in the selection process during adolescence. The aim of this study was to investigate the influence of skeletal age (SA) on the physical characteristics of elite male football players aged 13–15 years through a cross-sectional study. Methods and Materials We enrolled 167 elite players aged 13–15 from three academic football schools in China, and measured height, body mass, thigh circumference, skinfold (triceps and calf), 10 m/30-m sprint, T-tests (left and right), 5 × 25-m repeated-sprint ability (5 × 25 RSA), standing long jump, and YoYo intermittent recovery test level 1 (YYIR1). Subjects were divided into early-, average-, and late-maturity levels according to their SA and chronological age (CA) based on the following criteria: SA-CA > +1 year, SA-CA = ±1 year, and SA-CA < −1 year, respectively. The differences in parameters among the groups were analyzed using one-way analysis of variance and Bonferroni’s post-hoc test, with statistical significance set at p < 0.05. Results Relative to the late-maturing players, the early- and average-maturing players aged 13–15 years were taller, heavier, had a larger thigh circumference, and scored higher on the standing long jump, 30 m sprint, and 5 × 25-RSA (p < 0.05). The physical (except for body-fat percentage) and athletic characteristics of players aged 13–15 were not only significantly influenced by biological maturity, but also increased significantly with CA. The influence of biological maturity on height, 30-m sprints, and 5 × 25-m RSA diminished with age and exerted no significant effect on body-fat percentage and on YYIR1. Late-maturing players exhibited the greatest increase in physical (except for body-fat percentage) and athletic performance (except for the 10-m sprint) compared to players of early and/or average maturity. Conclusions Although early-maturing players aged 13–15 possessed better anthropometric and physical performance than late- and average-maturing players, the growth and development of physical function of late- and average-maturing players was significantly greater, particularly with respect to height, sprint speed, and muscular power.
Background Previous studies have shown controversial relationships between ACE I/D and ACTN3 R577x polymorphisms and athletic performance. Therefore, the aim of this study was to assess athletic performance indicators of Chinese youth male football players with different ACE and ACTN3 gene profiles. Methods and Materials This study recruited 73 elite (26 13-year-olds, 28 14-year-olds, and 19 15-year-olds) and 69 sub-elite (37 13-year-olds, 19 14-year-olds, and 13 15-year-olds) and 107 controls (63 13-year-olds, and 44 14-year olds aged 13–15 years, all participants were of Chinese Han origin. We measured height, body mass, thigh circumference, speed, explosive power, repeat sprints ability, and aerobic endurance in elite and sub-elite players. We used single nucleotide polymorphism technology to detect controls elite and sub-elite players’ ACE and ACTN3 genotypes, Chi-squared (χ2) tests were employed to test for Hardy-Weinberg equilibrium. χ2 tests were also used to observe the association between the genotype distribution and allele frequencies between controls and elite and sub-elite players. The differences in parameters between the groups were analyzed using one-way analysis of variance and a Bonferroni’s post-hoc test, with statistical significance set at p ≤ 0.05. Results (1) The genotype distribution of the ACE I/D and ACTN3 R577x polymorphisms in controls, elite and sub-elite football players were consistent with Hardy-Weinberg equilibrium, except for the ACE genotype distribution of sub-elite players. (2) The RR and DD genotypes were significantly different between elite and sub-elite players (p = 0.024 and p = 0.02, respectively). (3) Elite players were more likely to have the RR genotype and less likely to have the DD genotype compared with sub-elite players. (4) Both elite and sub-elite RR players’ Yo-yo intermittent recovery level 1 (YYIR1) running distance was significantly longer than that of RX players (p = 0.05 and p = 0.025, respectively). However, there was no significantly different in YYIR1 running distance between elite and sub-elite RR players. (5) Elite XX players’ VO2 max was significantly higher than that of RX and sub-elite players. Conclusion These results indicate that ACE I/D and ACTN3 R577x polymorphisms are not associated with muscle power in Chinese elite and sub-elite players. The XX genotype of ACTN3 is associated with the aerobic endurance of elite players.
The purpose of this study was to investigate the prevalence of ACTN3 polymorphisms in Chinese elite and sub-elite football players aged 13–15 years at different positions. Specifically we explored whether ACTN3 genotypes were linked with athletic performance of elite and sub-elite players at different positions. The RR genotype frequency of elite defenders (p = 0.018) and midfielders (p = 0.008) was significantly higher than that of sub-elite XX genotype in elite players. Furthermore, the R allele frequency of elite defenders (p = 0.003) and midfielders (p = 0.008) was significantly higher than that of sub-elite players. In all subjects, RR players performed faster and exhibited more explosive power than RX or XX players. RR, RX and XX elite players’ 20 m/30 m sprint, 5 × 25-m repeated sprint ability (5 × 25 m RSA), and standing long jump were stronger than sub-elite players, but there was no significant different in aerobic endurance between elite and sub-elite players at different positions. In conclusion, there were significant differences in ACTN3 genotypes and alleles between elite and sub-elite players at different positions, and the RR genotype was significantly associated with power-related athletic performance in Chinese youth football players.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.